Literature DB >> 21543483

Beta interferon controls West Nile virus infection and pathogenesis in mice.

Helen M Lazear1, Amelia K Pinto, Matthew R Vogt, Michael Gale, Michael S Diamond.   

Abstract

Studies with mice lacking the common plasma membrane receptor for type I interferon (IFN-αβR(-)(/)(-)) have revealed that IFN signaling restricts tropism, dissemination, and lethality after infection with West Nile virus (WNV) or several other pathogenic viruses. However, the specific functions of individual IFN subtypes remain uncertain. Here, using IFN-β(-)(/)(-) mice, we defined the antiviral and immunomodulatory function of this IFN subtype in restricting viral infection. IFN-β(-)(/)(-) mice were more vulnerable to WNV infection than wild-type mice, succumbing more quickly and with greater overall mortality, although the phenotype was less severe than that of IFN-αβR(-)(/)(-) mice. The increased susceptibility of IFN-β(-)(/)(-) mice was accompanied by enhanced viral replication in different tissues. Consistent with a direct role for IFN-β in control of WNV replication, viral titers in ex vivo cultures of macrophages, dendritic cells, fibroblasts, and cerebellar granule cell neurons, but not cortical neurons, from IFN-β(-)(/)(-) mice were greater than in wild-type cells. Although detailed immunological analysis revealed no major deficits in the quality or quantity of WNV-specific antibodies or CD8(+) T cells, we observed an altered CD4(+) CD25(+) FoxP3(+) regulatory T cell response, with greater numbers after infection. Collectively, these results suggest that IFN-β controls WNV pathogenesis by restricting infection in key cell types and by modulating T cell regulatory networks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543483      PMCID: PMC3126609          DOI: 10.1128/JVI.00396-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

Review 1.  Innate immune recognition of viral infection.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2006-02       Impact factor: 25.606

2.  Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN.

Authors:  Agnes Le Bon; Clare Thompson; Elisabeth Kamphuis; Vanessa Durand; Cornelia Rossmann; Ulrich Kalinke; David F Tough
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

3.  PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons.

Authors:  Melanie A Samuel; Kevin Whitby; Brian C Keller; Anantha Marri; Winfried Barchet; Bryan R G Williams; Robert H Silverman; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  CD8+ T cells require perforin to clear West Nile virus from infected neurons.

Authors:  Bimmi Shrestha; Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis.

Authors:  Robyn S Klein; Eugene Lin; Bo Zhang; Andrew D Luster; Judy Tollett; Melanie A Samuel; Michael Engle; Michael S Diamond
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Effects of type I interferons on Friend retrovirus infection.

Authors:  Nicole Gerlach; Simone Schimmer; Siegfried Weiss; Ulrich Kalinke; Ulf Dittmer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection.

Authors:  Elizabeth S Coro; W L William Chang; Nicole Baumgarth
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

9.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.

Authors:  Ganesh A Kolumam; Sunil Thomas; Lucas J Thompson; Jonathan Sprent; Kaja Murali-Krishna
Journal:  J Exp Med       Date:  2005-08-29       Impact factor: 14.307

10.  Protective immune responses against West Nile virus are primed by distinct complement activation pathways.

Authors:  Erin Mehlhop; Michael S Diamond
Journal:  J Exp Med       Date:  2006-05-01       Impact factor: 14.307

View more
  59 in total

1.  Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

Review 2.  The innate immune playbook for restricting West Nile virus infection.

Authors:  Kendra M Quicke; Mehul S Suthar
Journal:  Viruses       Date:  2013-10-30       Impact factor: 5.048

3.  Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.

Authors:  Lindsey E Cook; Marissa C Locke; Alissa R Young; Kristen Monte; Matthew L Hedberg; Raeann M Shimak; Kathleen C F Sheehan; Deborah J Veis; Michael S Diamond; Deborah J Lenschow
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

4.  The interferon-inducible gene viperin restricts West Nile virus pathogenesis.

Authors:  Kristy J Szretter; James D Brien; Larissa B Thackray; Herbert W Virgin; Peter Cresswell; Michael S Diamond
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

5.  Type I interferons: diversity of sources, production pathways and effects on immune responses.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Curr Opin Virol       Date:  2011-11-25       Impact factor: 7.090

6.  Type I interferon protects mice from fatal neurotropic infection with Langat virus by systemic and local antiviral responses.

Authors:  Elvira Weber; Katja Finsterbusch; Richard Lindquist; Sharmila Nair; Stefan Lienenklaus; Nelson O Gekara; Dirk Janik; Siegfried Weiss; Ulrich Kalinke; Anna K Överby; Andrea Kröger
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

7.  Subcapsular sinus macrophages limit dissemination of West Nile virus particles after inoculation but are not essential for the development of West Nile virus-specific T cell responses.

Authors:  Evandro R Winkelmann; Douglas G Widman; Jingya Xia; Alison J Johnson; Nico van Rooijen; Peter W Mason; Nigel Bourne; Gregg N Milligan
Journal:  Virology       Date:  2014-01-10       Impact factor: 3.616

Review 8.  West Nile Virus: biology, transmission, and human infection.

Authors:  Tonya M Colpitts; Michael J Conway; Ruth R Montgomery; Erol Fikrig
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication.

Authors:  Larissa B Thackray; Erning Duan; Helen M Lazear; Amal Kambal; Robert D Schreiber; Michael S Diamond; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

10.  The Interferon-Stimulated Gene IFITM3 Restricts Infection and Pathogenesis of Arthritogenic and Encephalitic Alphaviruses.

Authors:  Subhajit Poddar; Jennifer L Hyde; Matthew J Gorman; Michael Farzan; Michael S Diamond
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.